ATE106945T1 - Methoden und materialien für die hiv-erkennung und therapie. - Google Patents

Methoden und materialien für die hiv-erkennung und therapie.

Info

Publication number
ATE106945T1
ATE106945T1 AT88301369T AT88301369T ATE106945T1 AT E106945 T1 ATE106945 T1 AT E106945T1 AT 88301369 T AT88301369 T AT 88301369T AT 88301369 T AT88301369 T AT 88301369T AT E106945 T1 ATE106945 T1 AT E106945T1
Authority
AT
Austria
Prior art keywords
antibodies
hiv
monoclonal
reactive
disclosed
Prior art date
Application number
AT88301369T
Other languages
English (en)
Inventor
Tsuneya Ohno
Original Assignee
Nissin Food Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Ltd filed Critical Nissin Food Products Ltd
Application granted granted Critical
Publication of ATE106945T1 publication Critical patent/ATE106945T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-CD4 Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88301369T 1987-02-19 1988-02-18 Methoden und materialien für die hiv-erkennung und therapie. ATE106945T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1628287A 1987-02-19 1987-02-19
US6406687A 1987-06-29 1987-06-29
US14637188A 1988-02-03 1988-02-03

Publications (1)

Publication Number Publication Date
ATE106945T1 true ATE106945T1 (de) 1994-06-15

Family

ID=27360536

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91202465T ATE147759T1 (de) 1987-02-19 1988-02-18 Verfahren und materialien zum nachweis und therapie von hiv
AT88301369T ATE106945T1 (de) 1987-02-19 1988-02-18 Methoden und materialien für die hiv-erkennung und therapie.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT91202465T ATE147759T1 (de) 1987-02-19 1988-02-18 Verfahren und materialien zum nachweis und therapie von hiv

Country Status (5)

Country Link
EP (2) EP0468601B1 (de)
JP (1) JP2583555B2 (de)
AT (2) ATE147759T1 (de)
AU (1) AU609447B2 (de)
DE (2) DE3855761T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0385909T3 (da) * 1989-03-03 1994-08-15 Microgenesys Inc Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
WO1992022579A1 (en) * 1991-06-19 1992-12-23 Immulogic Pharmaceutical Corporation MIMIC PEPTIDES OF gp120
CA2194784A1 (en) * 1994-07-13 1996-02-01 Graham P. Allaway Articles of manufacture for removing hiv-1 from a sample, and methods of using same
AU3733499A (en) * 1998-05-25 1999-12-13 Asahi Kasei Kogyo Kabushiki Kaisha Cell separation device and separation method
CN112362864B (zh) * 2021-01-12 2021-04-30 广州科方生物技术股份有限公司 一种降低免疫诊断试剂背景发光值的处理剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DK152517B (da) * 1985-08-21 1988-03-07 Nordisk Gentofte Fremgangsmaade til paavisning af infektioes aids-virus
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
JPH01503381A (ja) * 1986-07-23 1989-11-16 アフトン　コーポレーション 免疫原ならびに改良された免疫原製造法
EP0280710B1 (de) * 1986-08-21 1996-03-20 The Trustees Of Columbia University In The City Of New York Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines

Also Published As

Publication number Publication date
DE3889945D1 (de) 1994-07-14
EP0468601A1 (de) 1992-01-29
EP0280468A3 (en) 1990-09-05
EP0468601B1 (de) 1997-01-15
JPS63294795A (ja) 1988-12-01
ATE147759T1 (de) 1997-02-15
DE3855761D1 (de) 1997-02-27
DE3855761T2 (de) 1997-06-05
DE3889945T2 (de) 1995-01-19
JP2583555B2 (ja) 1997-02-19
EP0280468B1 (de) 1994-06-08
AU609447B2 (en) 1991-05-02
EP0280468A2 (de) 1988-08-31
AU1190388A (en) 1988-09-01

Similar Documents

Publication Publication Date Title
DE68925226D1 (de) Monoklonale Antikörper
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
FI851334A0 (fi) Nya monoklonala antikroppar och hybridomaceller, foerfarande foer framstaellning av desamma samt deras anvaendning.
FI97813B (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
PH25120A (en) Replicable expression vehicle and process of preparation thereof
Lee et al. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
DE69132762D1 (de) Menschliche, monoklonale Antikörper gegen das transmembrane Glycoprotein (gp41) des HIV-1, und verwandte Peptide
ATE106945T1 (de) Methoden und materialien für die hiv-erkennung und therapie.
DE3854550D1 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
ES8505406A1 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
IL80718A (en) Murine derived hybridoma cell lines producing monoclonal antibodies to human pluripotent granulocyte colony stimulating factor
Lima et al. Immune responses during human Schistosomiasis mansoni. Evidence for antiidiotypic T lymphocyte responsiveness.
DE3879085D1 (de) Snrnp-a-antigen und fragmente davon.
DE3889581D1 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
NO861577L (no) Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering.
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE3855280D1 (de) Von mca 16-88 erkanntes antigen
SE8803062L (sv) Sekvensiella polypeptider med immunologisk aktivitet
ATE86261T1 (de) Tumorassoziiertes antigen.
FR2601037B1 (fr) Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
BE899484A (fr) Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties